Looking for representation in the Elmiron lawsuit? Our experience, expertise, and resources make Hollis Law the ideal partner.
Elmiron is used to treat a chronic bladder condition known as interstitial cystitis (IC), or “painful bladder syndrome.” This medication is also prescribed for osteoarthritis and can even be used as a weaker type anticoagulant. Elmiron’s active ingredient is pentosan polysulfate sodium (PPS). It is believed that Elmiron works to treat interstitial cystitis by attempting to repair the protective lining that coats the bladder wall.
If you’ve been affected by this drug, contact us to learn how we can represent you in the Elmiron lawsuit.
Call the Hollis Law Firm at 1-800-701-3672 if you or a loved one has taken this medication since 2013 and developed cancer. All calls and case evaluations are free and carry no obligation. The Hollis Law Firm works on cases on a contingent fee basis, which means we don’t get paid if you don’t get paid. Call 1-800-701-3672 to speak to one of our trained intake specialist so that your potential cancer claim can be reviewed by an attorney at the Hollis Law Firm. The injuries and damages caused by contaminated products will not be uniform; therefore, claims will need to proceed on an individual basis and not as part of a class action.
The RPE layer of the retina has many vital jobs in the function of the eye that include transforming critical molecules necessary for the visual cycle and protecting the eye by secreting immunosuppressive responses. The damage caused to the RPE by Elmiron may lead to pigmentary maculopathy, a deterioration of the central portion of the retina.
History of the Case
In November 2018, an article published by the American Academy of Ophthalmology from a study done at the Emory Eye Center, stated that patients taking Elmiron to treat IC reported difficulty reading, blurry vision, and an inability to adapt to darkness. Researchers believe that prolonged exposure to Elmiron can cause injury to the retinal pigment epithelium (RPE) of the eye.
Injuries Related to Product
Eye Damage, specifically to the Pigmentary Maculopathy, which is one of a number of disorders that affect the macula, the central portion of the retina.
Signs and Symptoms:
- Parafoveal pigmented deposits caused by abnormal capillaries and small blood vessels. This may result in vision loss.
- Vitelliform deposits, or round and yellow lesions formed underneath the macula.
- Retinal pigment epithelium atrophy
- Dark spots on the retina
Pearce, WA., Chen, R., Jain, N. Pigmentary maculopathy associated with chronic exposure to pentosan polysulfate sodium. Ophthalmology 2018;126:7:1793-1802.
Simó R., Villarroel, M., Corraliza, L., Hernández, C., Garcia-Ramírez, M. The Retinal Pigment Epithelium: something More than a Constituent of the Blood-Retinal Barrier-Implications for the Pathogenesis of Diabetic Retinopathy. Journal of Biomedicine and Biotechnology. 2009; 2010; 190724